Tag: Comparison
Oncology vs Biosimilar: Which Therapeutic Focus for Foreign Pharma in China?
Oncology vs Biosimilar: Which Therapeutic Focus for Foreign Pharma in China? body { font-family: 'Segoe UI', Arial, sans-serif; line-height: 1.8; colo
NRDL vs Private Insurance: Which Pricing Approach for Foreign Pharma in China?
NRDL vs Private Insurance: The Pricing Fork in the Road for Foreign Pharma in China For foreign pharmaceutical companies entering China, the decision
Chinese Court vs Foreign Arbitration: Which Enforcement Route in China?
Chinese Court vs Foreign Arbitration: Which Enforcement Route in China? When enforcing commercial agreements in China, executives face a fundamental c
ICC vs CIETAC Arbitration: Which Forum for China Contracts?
ICC vs CIETAC Arbitration: Which Forum for China Contracts? When drafting dispute resolution clauses for China contracts, choosing between ICC (Intern
Patent License vs Know-How License: Which Licensing Approach?
Patent License vs Know-How License: Which Licensing Approach? In China, over 250,000 technology licensing agreements are registered annually with the
NDA Only vs NDA + Non-Compete: Which Trade Secrets Protection Approach in China?
NDA Only vs NDA + Non-Compete: Which Trade Secrets Protection Approach in China? In 2024, Chinese courts handled over 5,200 trade secret disputes, wit